ARGS

Argos Therapeutics, Inc.
ARGS

Overview Fund Activity
Delisted

ARGS was delisted on the 24th of April, 2018.

Back to rankings

28 hedge funds and large institutions have $456K invested in Argos Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
8
Reduced
9
Closed
6
Calls
$615K
Puts
–
Net Calls
+$615K
Net Calls Change
-$305K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$29.2K
2
VF
Virtu Financial
New York
+$9.84K
3
WS
Wedbush Securities
California
+$6.05K
4
SMH
Sanders Morris Harris
Texas
+$4.32K
5
CLOS
Compagnie Lombard Odier SCmA
Switzerland
+$4K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$32K
2
TSS
Two Sigma Securities
New York
-$14.9K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$8.37K
4
HighTower Advisors
HighTower Advisors
Illinois
-$5K
5
WA
Wasatch Advisors
Utah
-$3.37K
Name Holding Trade Value Shares
Change 		Shares
Change %
BNP Paribas Financial Markets
26
BNP Paribas Financial Markets
France
– -$1 – –
1
2